Evidence map›Paper›PMID 37009253›Full record

ArticleVirusdisease2023

Molecular characterization of the neuraminidase gene of

Kimia Kaveh, Abbas Tazarghi, Parastoo Hosseini, Fatemeh Fotouhi, Mehdi Ajorloo, Mehdi Rabiei Roodsari, Hadi Razavi Nikoo

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virusdisease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Exploring molecular characterization circulating influenza A and B viruses in Tehran, Iran.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Kimia KavehDepartment of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Abbas TazarghiDepartment of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.ORCID 0000-0001-6666-3489
Parastoo HosseiniDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh FotouhiInfluenza Research Lab, Department of Virology, Pasteur Institute of Iran, Tehran, Iran.
Mehdi AjorlooBlood Transfusion Research Center, High Institute of Research and Education in Transfusion Medicine, Tehran, Iran.
Mehdi Rabiei RoodsariDepartment of Microbiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Hadi Razavi NikooDepartment of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Golestan University · IRHigh Institute for Education and Research in Transfusion Medicine · IRMazandaran University of Medical Sciences · IRPasteur Institute of Iran · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuraminidase inhibitors are the only FDA-approved class of antiviral agents against

Indexed as

Drug resistanceEpitopesInfluenza BNeuraminidaseNeuraminidase inhibitors

Identifiers

PMID37009253
PMCPMC10050514
OpenAlexW4321239598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.